InsiderClue
Insiders · Profile

HERRING JOSEPH L

Director at Henry Schein · CEO of Covance Drug Division at Labcorp. Filing since 25 Feb 2015. CIK 0001229873

HSIC Henry Schein Director · 2 trades LH Labcorp CEO of Covance Drug Division · 1 trade
Company
Date
Role
Action
Shares
Amount
Of holding
HSIC Henry Schein
30 Nov 2016
Director
Bought
71
$10.59K
10.2%
HSIC Henry Schein
3 Nov 2016
Director
Bought
196
$30.59K
34.3%
LH Labcorp
25 Feb 2015
CEO of Covance Drug Division
Sold, plan not stated
36,876
$4.49M
100%
3 decisions on file.